John P. Gonzalez, PhD, CMPP, Solanum Medical Communications, Macclesfield, UK Calls for urgent improvements in the design, registration, reporting, and transparency of preclinical studies have recently arisen (1). In an open letter to the USA Today newspaper published...
The first-ever ISMPP West meeting was filled with excitement and engagement for attendees from smaller biotech and pharmaceutical companies, as well as larger companies. The meeting program addressed a niche for those who work in publication teams – or are a...
ISMPP has exceeded 1,600 members – a new milestone in record membership! With 1,602 members as of August 31, 2018, the Society experienced a 10.3% increase in its membership from one year prior when ISMPP had 1,452 members. The main drivers of this growth were a...
Tom Drake, MA, CMPP, Global Outcomes Group, Reston, VA Publication professionals work in an industry experiencing a shift in required evidence related to a product’s value, as well as its safety and efficacy. They manage the release of clinical and economic data that...
Rhonda Croxton, PhD, Judy Fallon, PharmD, Jeffrey Keller, ICON plc (formerly The CHC Group), North Wales, PA One of the most essential responsibilities that medical communications agencies possess is the promise to maintain the confidentiality of their...
ISMPP Insider is an informational and educational service intended for ISMPP members and the broader medical communications community. It is not meant as a basis for individual companies to make policy and/or procedural decisions, which should be made in consultation with the company’s Legal and/or Compliance representatives. The articles in ISMPP Insider do not necessarily represent the views of ISMPP.
ISMPP will grant limited permission to use postings and articles in ISMPP Insider for personal and noncommercial use. Permission requests or questions should be directed to ISMPP (ismpp@ismpp.org).
